Welcome to the Institute of Clinical Research

Welcome to the Institute of Clinical Research

About Us

The Institute of Clinical Research (ICR) is the probably the oldest independent membership-led professional body for global clinical researchers.  

For over 40 years, The Institute of Clinical Research (ICR) has provided high quality training, networking and support to the clinical research community.  For many Members the Institute has been part of their life throughout their working careers, many have been with the Institute since its first incarnation as the ACRPI.

It is the membership that makes the Institute.

How does it all work ?

The Institute of Clinical Research is you, the Membership governed by the Articles of Memorandum drawn up by the founding members.

The Board is made up of members who give their time freely to guide the future direction of the ICR.

The ICR Secretariat is the administrative arm of the Institute, its primary focus is to ensure that the wishes of the Board and Membership are carried out and to see to the day to day tasks that any membership organisation generates.

  

Our Mission

The ICR exists to support our members through all stages of their careers. We do this, in part, by:

  • Defining and refining standards for our profession
  • Providing a forum for discussion of key issues impacting clinical research
  • Promoting good relations with other healthcare related groups 
  • Providing opportunities for learning and development to enhance professional competence 
  • Enhancing public confidence and understanding of clinical research

 

Current News

ONLY 2 WEEKS to go until Ethics & GCP Forum - Thursday 18th March

By ICR Secretariat / 04/03/2021 03:55 PM

With only 2 weeks to go until our biannual Ethics & GCP Forum, places are filling up fast!

This Forum will be running online via Zoom.

BOOK NOW to…

Moderna, Pfizer ready multi-pronged plans for coronavirus variants

By ICR Secretariat / 04/03/2021 02:17 PM

  • Moderna and Pfizer are progressing plans to test additional booster shots or modified vaccines tailored to a coronavirus variant originally detected …

ICON to acquire PRA Health Sciences in $12bn deal

By ICR Secretariat / 04/03/2021 02:16 PM

Dublin-based clinical trials group ICON is set to acquire rival contract research organisation (CRO) PRA Health Sciences in a deal worth approximately…


What you need to know about the coronavirus right now

By ICR Secretariat / 04/03/2021 02:14 PM

Europe reviewing Russia’s COVID-19 vaccine

Europe’s medicines regulator said on Thursday it has started a review of the Sputnik V COVID-19 vaccine dev…

COVID-19 collaborations could ‘unlock’ the potential of the UK’s life sciences sector

By ICR Secretariat / 24/02/2021 12:18 PM

A new report by Novartis UK has recommended continuing collaboration across the life sciences sector in the UK after identifying enhanced collective e…

Evidence looks good on COVID vaccines cutting transmission: UK minister

By ICR Secretariat / 24/02/2021 12:16 PM

LONDON (Reuters) - The evidence indicates that vaccines are proving effective at cutting the transmission of COVID-19, Britain’s vaccines minister sai…


Pfizer, BioNTech ask FDA approval to ease temperature requirements for coronavirus shot

By ICR Secretariat / 24/02/2021 12:15 PM

Ethics & GCP Forum - Updated Agenda!

By ICR Secretariat / 23/02/2021 01:11 PM

UPDATED AGENDA

Agenda 

09:30 Online Registration/Dial-in

10:00 Welcome

           Ethics Forum

10:10 MHRA Update incl. Brexit

           Kirsty Wydenb…

A gene therapy pipeline takes shape for a cluster of rare diseases

By ICR Secretariat / 17/02/2021 10:55 AM

The toxic globules of sugar and fat slowly pile up in the body's cells, accumulating in blood vessels and in major organs like the kidney and heart.


CureVac’s COVID-19 vaccine begins rolling review with EMA

By ICR Secretariat / 17/02/2021 10:53 AM

German biopharmaceutical company CureVac has announced the initiation of a rolling review with the European Medicines Agency (EMA) for its mRNA-based …

In surprise finding, Roche arthritis drug cuts risk of COVID-19 death in large UK study

By ICR Secretariat / 17/02/2021 10:52 AM

  • An anti-inflammatory drug from Roche cut the risk of death in patients hospitalized with severe COVID-19, investigators in a massive British trial kn…

Multiple rolling reviews kick-off for Novavax’s COVID-19 vaccine

By ICR Secretariat / 10/02/2021 12:58 PM

Rolling reviews of Novavax’s COVID-19 vaccine have kicked-off in the UK, US, EU and Canada following the recent announcement that the jab demonstrated…


Ethics & GCP March 2021 Open for Bookings

By ICR Secretariat / 26/01/2021 12:28 PM

The ICR Ethics & GCP Forum
Thursday 18th March 2021

Venue: This forum will run virtually online via Zoom

Agenda 

09:30    Online Registratio…



Events and Courses

Vendor Oversight in Clinical Trials K7

This course will run ONLINE VIA ZOOM. Vendor Oversight is currently a hot topic as sponsors and vendors aim to get to grips with what is really requir...


The ICR Ethics & GCP Forum EGCP

Agenda&nbsp; <b style...


Introduction To Clinical Trials & Clinical Trials Practice J31

THIS COURSE HAS BEEN POSTPONED DUE TO NATIONAL LOCKDOWN An Introduction to Clinical Trials and Clinical Trial Practice, the ICR’s flagshi...


Clinical Investigations for Medical Devices - Foundation K8

In this one day course we explore clinical investigations for medical devices. &nbsp;We will review the latest legislation and its impact on determini...


Clinical Trial Administration - Beyond the Basics K9

Clinical Trial Administrators are at the heart of any project team...


Advanced Monitoring K10

In this highly practical course we look at the root cause of typical inspection findings and work with delegates to develop personal corrective a...


Current Jobs